These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26015406)

  • 1. Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment.
    Chen CH; Cheng CT; Yuan Y; Zhai J; Arif M; Fong LW; Wu R; Ann DK
    Oncotarget; 2015 Jun; 6(17):15194-208. PubMed ID: 26015406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.
    Chen CH; Thai P; Yoneda K; Adler KB; Yang PC; Wu R
    Oncogene; 2014 Jul; 33(28):3696-706. PubMed ID: 23955080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.
    Chen CH; Statt S; Chiu CL; Thai P; Arif M; Adler KB; Wu R
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1127-38. PubMed ID: 25318062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
    Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD
    Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS).
    Tatsumi S; Mabuchi T; Katano T; Matsumura S; Abe T; Hidaka H; Suzuki M; Sasaki Y; Minami T; Ito S
    Neuroscience; 2005; 131(2):491-8. PubMed ID: 15708490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
    Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
    Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo.
    Rombouts K; Carloni V; Mello T; Omenetti S; Galastri S; Madiai S; Galli A; Pinzani M
    Cancer Lett; 2013 Jun; 333(2):244-52. PubMed ID: 23376641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristoylated alanine-rich C kinase substrate (MARCKS) regulates the expression of proinflammatory cytokines in macrophages through activation of p38/JNK MAPK and NF-κB.
    Lee SM; Suk K; Lee WH
    Cell Immunol; 2015 Aug; 296(2):115-21. PubMed ID: 25929183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of myristoylated alanine-rich C kinase substrate is involved in the cAMP-dependent amylase release in parotid acinar cells.
    Satoh K; Matsuki-Fukushima M; Qi B; Guo MY; Narita T; Fujita-Yoshigaki J; Sugiya H
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1382-90. PubMed ID: 19372103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PhosphoMARCKS drives motility of mouse melanoma cells.
    Chen X; Rotenberg SA
    Cell Signal; 2010 Jul; 22(7):1097-103. PubMed ID: 20211725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils.
    Sheats MK; Pescosolido KC; Hefner EM; Sung EJ; Adler KB; Jones SL
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):167-76. PubMed ID: 24857637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
    Quan R; Ning Z; Wang Y; Yu W; Zhu H
    Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.
    Liu J; Chen SJ; Hsu SW; Zhang J; Li JM; Yang DC; Gu S; Pinkerton KE; Chen CH
    Theranostics; 2021; 11(9):4122-4136. PubMed ID: 33754052
    [No Abstract]   [Full Text] [Related]  

  • 16. MARCKS regulates lamellipodia formation induced by IGF-I via association with PIP2 and beta-actin at membrane microdomains.
    Yamaguchi H; Shiraishi M; Fukami K; Tanabe A; Ikeda-Matsuo Y; Naito Y; Sasaki Y
    J Cell Physiol; 2009 Sep; 220(3):748-55. PubMed ID: 19475567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MARCKS dephosphorylation is involved in bradykinin-induced neurite outgrowth in neuroblastoma SH-SY5Y cells.
    Tanabe A; Shiraishi M; Negishi M; Saito N; Tanabe M; Sasaki Y
    J Cell Physiol; 2012 Feb; 227(2):618-29. PubMed ID: 21448919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.
    Bickeböller M; Tagscherer KE; Kloor M; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Toth C; Schirmacher P; Roth W; Bläker H
    Oncogene; 2015 Feb; 34(9):1150-9. PubMed ID: 24662837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.